Metals often determine the chemical reactivity of the proteins to which they are bound. Each cell in the body tightly maintains a unique metalloproteomic profile, mostly dependent on function. This paper 10 describes an analytical online flow injection quantitative size exclusion chromatography-inductively coupled plasma-mass spectrometry (SEC-ICP-MS) method, which was applied to profiling the metalbinding proteins found in primary cultures of neurons and astrocytes. This method can be conducted using similar amounts of sample to those used for Western blotting (20-150 µg protein), and has a turnaround time of < 15 minutes. Metalloprotein standards for Fe (as ferritin), Cu and Zn (as superoxide 15 dismutase-1) were used to construct multi-point calibration curves for online quantification of metalloproteins by SEC-ICP-MS. Homogenates of primary neuron and astrocyte cultures were analysed by SEC-ICP-MS. Online quantification by external calibration with metalloprotein standards determined the mass of metal eluting from the column relative to time (as pg s -1 ). Total on-column Fe, Cu and Zn detection limits ranged from 0.825 ± 0.005 ng to 13.6 ± 0.7 pg. Neurons and astrocytes exhibited distinct 20 metalloprotein profiles, featuring both ubiquitous and unique metalloprotein species. Separation and detection by SEC-ICP-MS allows appraisal of these metalloproteins in their native state, and online quantification was achieved using this relatively simple external calibration process.
Profiling the iron, copper and zinc content in primary neuron and astrocyte cultures by rapid online quantitative size exclusion chromatography-inductively coupled plasma-mass spectrometry Dominic 
Introduction
The brain maintains some of the highest concentrations of metals 25 in the body. 1 Free alkali and alkaline earth metals play important roles in the transmission of nerve impulses and signal transduction, whilst transition metals, including Fe, Cu and Zn mediate a variety of cellular functions by way of their unique redox chemistry. Concentrations of these metals in the brain 30 range from 10 to 100 µM, depending on the organelle and cell type in which they are found, 2 and the brain must tightly regulate the chemical state of these transition metals to ensure oxidative stress via metal-mediated Fenton and Haber-Weiss-type chemistry is controlled. Increasing evidence has suggested 35 improper transition metal metabolism may contribute to the pathogenesis of various neurological disorders, including Alzheimer's and Parkinson's disease, through generation of toxic reactive oxygen species by labile metal ions. 3 The source of oxidative stress-inducing metal species is a 40 continuous point of contention with regard to the brain. Fe, Cu and Zn are distributed throughout the brain in a highly compartmentalised manner, 4 reflective of the diverse roles metal species play across the most complex organ in the body. Indeed, metal distribution is likely to be equally distinct at the cellular 45 level, both with regard to total metal content and the protein species to which they are bound.
As such, we set out to examine the distribution of Fe, Cu and Zn according to the molecular species in two of the major cell types found throughout the brain: neurons and astrocytes. 50 Interactions between these cell types govern a huge amount of neurophysiological processes, from development to pathology; yet detailed study of the chemistry surrounding the relationship of these two integral cells has been somewhat limited by the lack of suitably sensitive analytical techniques. Rapid improvements to 55 analytical technology have helped remove a key challenge to understanding both the nature of brain function and how it is compromised in disease. Cahoy et al. 5 recently applied both fluorescence-activated cell sorting and GeneChip Array technology to profile the transcriptome of neurons, astrocytes and 60 oligodendrocytes, finding that the genetic characteristics of the latter two cell types were so markedly different that previous generic classification of them both as 'glia' is likely insufficient. Yang et al. 6 used a proteomic approach to characterise the diversity of chemical species in rat cerebellar neurons and differentiate astrocytes and neurons then the traditional glial fibrillary acidic protein (GFAP) marker.
Thus, there is little doubt that the metalloproteomic profile of neurons and astrocytes contains unique information regarding the host cell type. Further, proteins that have been implicated in 5 neurological diseases have also been suggested to play roles in metal metabolism, such as the Zn and Cu interactions with prion protein (PrP) 7 and proposed role of ionic Zn and Cu in the aggregation of β-amyloid (Aβ) in Alzheimer's disease. 3, 8 However, the ubiquity of trace metals (Fe, Cu and Zn in 10 particular) in the cell, as well as the relatively weak intermolecular forces governing metal-protein ligands presents an analytical challenge to achieving separation and detection of physiologically-relevant species. [9] [10] [11] Only fractionation of complex biological mixtures, usually via chromatographic 15 separation, can provide clues as to whether changes in metal levels observed in neurological tissues are global or confined to a particular protein, and this protocol must ensure that metalprotein ligands are preserved. Lelie et al. 12 recently used such an approach to show that Cu,Zn-superoxide dismutase (SOD-1) 20 metallation status, specifically the absence of Cu, was an identifying feature of familial amyotrophic lateral sclerosis (ALS).
Here, we employed native separation using size exclusion chromatography (SEC) hyphenated to ICP-MS for detection of 25 metal cofactors according to molecular weight of the eluting biomolecules. Coupling SEC to elemental detection itself is not a new analytical technique; the first featured examples, reported in the 1980s, used atomic absorption 13 and atomic emission spectrometry 14 to detect trace metals in various biological fluids. 30 Since then, a number of examples of SEC hyphenated to mass specific detection have been used to study trace metals in a variety of physiological and disease states, including rat serum, 15 cancerous human thyroid tissue, 16 murine neurological tissue 17 and platinum-treated human blood products 18 to name just a few. 35 A common theme to these foundation papers is lengthy runtimes and difficulties in acquiring truly quantitative data. Using standard metalloproteins, we were able to absolutely quantify the metal content of each eluting species, and have suggested the possible biological molecules associated with specific metal ions. 40 We present a method that is well suited to high throughput analysis of biological samples relevant to the emerging field of metalloproteomics 19 using minimal sample volumes and rapid chromatographic separations.
Experimental

45
Chemicals and standards
SOD-1 (Cu,Zn) and ferritin (Fe; Sigma Aldrich, Castle Hill, Australia) protein standards were used for metal quantification. Ammonium nitrate buffers were prepared fresh daily using MiliQ (18.2 MΩ) H 2 O. All samples undergoing solution ICP-MS 50 analysis for bulk metal content were diluted to volume in 1% (v/v) Suprapur HNO 3 . SEC column calibration was performed using molecular weight standards for ferritin (MW = 450 kDa), ceruloplasmin (MW = 151 kDa), conalbumin (MW = 75 kDa; GE Healthcare, Rydalmere, Australia), SOD-1 (MW = 32 kDa 55 (dimer)) and metallothionein IIa (MW = 6.5 kDa). Liquid chromatography-inductively coupled plasma-mass spectrometry 60 We used an Agilent Technologies 1200 liquid chromatography system (Mulgrave, Australia) with the eluent directly inserted into a standard perfluoroalkoxy (PFA) concentric design nebuliser via polyethyl ether ketone ( Table 1 .
External calibration
SOD-1 and ferritin standards were prepared fresh prior to 75 analysis. Standards were reconstituted in 0.1 M phosphate buffered saline (PBS) and total metal content was determined by bulk ICP-MS analysis. Total metal loading on column was controlled by varying the injection volume from 3 to 75 µL. The area under baseline-corrected peaks was integrated using Prism 5 80 (GraphPad, La Jolla, USA) and used to construct multi-point calibration curves for each measured mass. Linear regression analysis was used to convert signal intensity (counts per second) to picogram of metal per second.
Primary cell cultures
85
Primary murine culture protocols were approved by the University of Melbourne Biosciences Animal Ethics Committee (approval number 1011753.4). For primary cortical cultures, E14 mouse cortices were removed, dissected free of meninges and dissociated in 0.025% trypsin. Viable dissociated cells were 90 suspended in Minimum Eagle's Medium supplemented with 10% fetal bovine serum, 5% horse serum, 1% glutamine, and 10 µg mL -1 gentamicin, plated into poly-L-lysine coated 6 well culture plates (1.5 x 10 6 cells per well), and incubated at 37 °C in 5% CO 2 . Growth medium was replaced with Neurobasal growth medium supplemented with 2% B27, 1% glutamine and 10 µg mL -1 gentamicin the following day. 3-4 days after plating, half of the media was replaced with fresh Neurobasal media. Cells were 10 used for experiments 6 days after plating.
For astrocyte cultures, neonatal mice were decapitated and whole brains were removed and placed into ice-cold preparation buffer (containing 8 g L 200 U mL -1 penicillin and 200 µg mL -1 streptomycin). Brains were sequentially passed through 250 µm and 135 µm gauze and centrifuged at 500 g for 5 min. Cell pellets were resuspended in growth medium (high glucose DMEM containing 10% fetal bovine serum, 50 U mL -1 penicillin and 50 µg mL -1 streptomycin) 20 and plated in 6 well plates at 1.5 x 10 6 cells per well. Cells were maintained at 37 °C with 10% CO 2 . Growth medium was replaced at 7 and 14 days, and experiments were performed after 16 days in vitro. 25 Pellets of cultured neurons and astrocytes were resuspended in Tris-buffered saline (TBS; 50 mM Tris, 150 mM NaCl; pH 8.0) with added EDTA-free protease inhibitors (Roche, Castle Hill, Australia) and homogenized by 6 passes through a 26-gauge needle. The homogenate was then centrifuged at 13,200 g for 5 30 minutes and the supernatant recovered. Injection volumes were standardised according to total protein content (UV absorbance at 280 nm) of the sample (c.a. 10 µg µL -1 ) measured by a NanoDrop spectrophotometer (ThermoFisher Scientific, Victoria, Australia). Samples were kept at 4 °C prior to injection using a Peltier- 35 cooled autosampler. Each injection contained approximately 100 µg of total protein.
Sample preparation and analysis
Results and discussion
Analytical performance
External calibration using multiple injections of metalloproteins 40 standards enabled us to quantify both the total metal content in individual SEC-ICP-MS separations and the eluting metal concentration in pg s -1 . 20 Injection volumes ranged from 3 to 75 µL, for effective loading of 6-150 ng of Fe and 0.6-15 ng of Cu and Zn, which was in turn used to perform external calibration by 45 linear regression with good linearity (r 2 > 0.999) for the three measured masses (Fig. 1a-c) . Limits of analysis were determined weight determination (Fig. 1d) . This quantitative SEC-ICP-MS method is well suited to high throughput analysis. The shorter column (150 mm) than previous SEC-ICP-MS methods allows for smaller injection volumes (1-100 µL per injection) and reduced turnaround time per sample 20 (<15 min). Quantification of metal content of neurons and astrocytes 25 Chromatograms for each measured mass were normalised to the total peak area of the 280 nm absorbance trace (in addition to preinjection standardisation using absorbance at 280 nm measured by UV-Vis spectroscopy), and thereby total protein content to confirm equivalent mass loading onto the SEC column. The total 30 peak area for each measured mass was used to determine the total metal loading on column, and thus the concentration of metal in the homogenate per 1 mg of total protein loaded ( Table 2 ). This approach allows for both speciation of metalloproteins and assay of the total metal content of cells. Interestingly, the total Fe 5 content of both neuronal and astrocytic cultures was lower than Cu and Zn, even though Fe is generally at a higher concentration in brain tissue, 21 suggesting that either high brain Fe is sourced from other cell types, such as Fe-rich oligodendrocytes, 22 or that typical cell culturing conditions are Fe-deficient. In fact, we have 10 previously observed that increase in astrocyte uptake of free Fe in metal-enriched (as ferric ammonium citrate; FAC) was as much as 20-fold 23 , while cellular uptake of ionic Cu and Zn was minimal 24, 25 . The Fe content of both cell types was comparable, however, to previously reported values using alternative 15 quantitative techniques, such as the ferrozine-based colourimetric assay 26 and atomic absorption spectroscopy. 27 Similarly, the Cu content of astrocytes 28 and neurons 29 was also analogous to previous reports, as was the basal level of Zn in both cell types compared to other cell culture studies. 30, 31 In general, astrocytes 20 contained a greater concentration of both Fe and Zn than neurons, while neurons contained around twice the Cu concentration to that of astrocytes. The method presented here demonstrates several significant advances in LC-ICP-MS separation and detection. Quantification 25 of eluting metals has previously required bulk assay of collected fractions, 32 which further weakens the already poor separation resolution experienced with native SEC separation. Online quantification via flow-injection calibration of standard metalloproteins allows for determination of the amount of metal 30 eluting from the column on a per-point basis. The half-peak width of moderately abundant metalloproteins was typically around 20 s, equivalent to approximately 14 points per peak. Integration of the area under curve (AUC) for each peak can feasibly be used to quantify total metal loading on species-specific metalloproteins, 35 adding to available options including quantification via isotopedilution ICP-MS. [33] [34] [35] 
Diversity in metalloproteins between cell types
Neurons and astrocytes predictably display a diverse range of metalloprotein species (Fig. 2,3) . The Fe-binding species of 40 neurons and astrocytes were generally comparable, with major Fe-containing peaks observed at approximately V e /V 0 (ratio of elution volume to void) = 1.55 (MW = 450 kDa) and V e /V 0 = 1.84 (MW = 80 kDa), as well as low mass species eluting after the total column volume (V T ; MW < 0.5 kDa). As expected, the 45 majority of Fe in both cell types is likely associated with high molecular weight ferritin (V e /V 0 = 1.55; MW = 450 kDa), and astrocytes were observed to contain as much as 10 times more ferritin-bound Fe than neurons. Ferritin is ubiquitously expressed in both neurons and astrocytes, the amount of which differs 50 depending on both brain region 36 and Fe homeostatic requirements. 37 The peak at V e /V 0 = 1.84 (MW = 80 kDa) is likely to be indicative of the major Fe-transport protein transferrin.
Ceruloplasmin (Cp; V e /V 0 = 1.74; MW 151 kDa) accounts for over 90% of circulating Cu and plays a major role in brain Fe 55 metabolism. 38 Interestingly, this protein was observed almost exclusively in neurons (see Fig. 2 ). Immunohistochemical studies of Cp in brain sections has previously identified expression in both cell types, 39 and it is unclear as to why cultured astrocytes do not display a Cu peak corresponding to Cp. A variety of Cu- 60 binding proteins and peptides have been identified in astrocytes, including transporters (Copper transporter receptor 1 -Ctr1; divalent metal transporter 1 -DMT1; ATP7A), intracellular traffickers (SOD-1, copper chaperone for superoxide dismutase -CSS; ATOX1, Cox17), and storage and detoxifiers such as Cox17 and ATOX1. 41 An extremely small peak is observed in astrocytes at V e /V 0 = 1.71 (MW = 178 kDa) may be indicative of Ctr1. 28 The Zn profile in both cell types was generally similar, with the exception of a major Zn binding protein at V e /V 0 = 2.32 (MW 5 = 4.1 kDa) in astrocytes not identified in neurons. A similar Cucontaining peak at V e /V 0 = 2.36 (MW = 3.2 kDa) is also observed in astrocytes. These peaks are thought to represent astrocytic expression of MT isoforms, which are high affinity Zn (and Cu) binders expressed in this cell type that play an important role in 10 the response to neuronal injury. [42] [43] [44] In situ hybridization, radioimmunoassay and immunohistochemistry has previously identified MT-I and -II expression in glia and ependymal cell cultures. 45 Growth conditions of both cell types may influence the 15 metalloprotein profile. Neurons were grown in serum-free Neurobasal medium (following an initial period on serumcontaining media), whilst astrocytes were grown in 10% fetal bovine serum. This difference may account for differing protein expression, though this also reflects the different extracellular 20 environments each cell type would maintain in vivo. Regardless, growing either cell type in a consistent serum-rich or serum-free environment would only serve to produce unviable cells, which would undoubtedly produce an artificial affect on protein diversity. This approach has greater utility in studying the cellular 25 response to metal dyshomeostasis: further work will examine shifts in metalloprotein species following the addition of bioavailable metals. However, a possible avenue of investigation could use a transient/separable co-culture system (reviewed by Miki et al. 46 ) in order to expose cells to the same growth media.
30
Global versus targeted metalloproteomics
The typical approach to metalloprotein analysis can best be described as a targeted method, where specific purification and sample cleanup steps precede direct measurement of a known species via electrospray MS, such as metallation status of SOD-1 35 in ALS spinal cord tissue 47, 48 and heavy metal-binding MT isoforms in hepatic and renal tissue [49] [50] [51] (see Eve Roberts' review 52 for a comprehensive synopsis of targeted metalloproteomic strategies from the perspective of hepatic disorders). The approach described here provides a 'global' 40 evaluation for comparative biology across a broad mass range, which allows for rapid identification of either generalised metal deficiency (as we observed with respect to Fe) or changes in a specific metal-binding peak, which may be a candidate for a more targeted metalloproteomic assay. For specific conditions, such as 45 familial ALS where metallation status of the abundant metalloenzyme is impaired, this approach provides not only sufficient native chromatographic resolution to isolate SOD-1, but also provides an accurate quantification method that can be related to protein-metal stoichiometry. As such, this rapid 50 quantitative technique has the potential to play an important role in the study of disorders involving impairment to metal metabolism.
Conclusions
Primary cultures of murine neurons and astrocytes contain a wide 55 range of metalloproteins, which can be quantified with relative simplicity using native SEC hyphenated to ICP-MS and a range of metalloprotein standards. Native chromatography allows direct detection of metal cofactors in a non-denaturing environment, ensuring that the relatively weak interactions typical of protein-60 metal complexes are preserved. Online quantitative SEC-ICP-MS extends the capabilities of hyphenated techniques to allow direct detection and quantification of metal cofactors, thus allowing meaningful biological comparison of the role of the metalloproteome in health and disease. 65 
